Skip to main content
. 2008 Mar 21;14(11):1670–1681. doi: 10.3748/wjg.14.1670

Figure 2.

Figure 2

RNAi targets that may be silenced to counter HCC. In addition to HBV and HCV genes, cellular sequences that are involved in hepatocyte transformation may be silenced to inhibit growth of malignant liver cells. Growth of HCC is also dependent on angiogenesis and inhibition of this process is expected to limit tumor growth.